Posts Tagged :

Shields Care Model

Shields PGY1 Community-Based Residency Program 70 70 Shields Health Solutions

Shields PGY1 Community-Based Residency Program

Launch Your Specialty Pharmacy Career with Expert Mentorship and Real-World Experience Are you a pharmacy student or recent graduate looking to elevate your career? The Shields PGY1 Community-Based Residency Program…

The Role of Health System Specialty Pharmacy in Cardiometabolic Disease Care 70 70 Shields Health Solutions

The Role of Health System Specialty Pharmacy in Cardiometabolic Disease Care

Unlock Better Outcomes in Cardiometabolic Disease Care Cardiometabolic disease (CMD) is one of the most pressing healthcare challenges of our time—driving trillions in costs and impacting millions of lives. From diabetes…

Artificial Intelligence in Specialty Pharmacy: Innovation That Empowers, Not Replaces 70 70 Shields Health Solutions

Artificial Intelligence in Specialty Pharmacy: Innovation That Empowers, Not Replaces

Will AI replace pharmacists and technicians? It’s a question that has sparked both curiosity and concern across the healthcare landscape, and understandably so, as artificial intelligence (AI) has already had…

Unlocking the Full Potential of Your DIY Specialty Pharmacy Program: Why Strategic Partnership Matters 70 70 Shields Health Solutions

Unlocking the Full Potential of Your DIY Specialty Pharmacy Program: Why Strategic Partnership Matters

Specialty pharmacy is one of the fastest-growing and most essential parts of today’s healthcare landscape — and you’re likely already feeling both the opportunity and the pressure. As the number…

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy 70 70 Shields Health Solutions

How CHRISTUS Health Reimagined Diabetes Support Through Health System Specialty Pharmacy

This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy 70 70 Shields Health Solutions

Analysis of Glucagon-Like Peptide-1 Agonist Trends Within An Integrated Health System Specialty Pharmacy

  According to the CDC, approximately 38 million Americans have diabetes (about 1 in 10) and approximately 90-95% of those have type 2 diabetes. GLP-1 and GLP-1/GIP agonists are now recognized…

Shields Outcomes 2024 Report 70 70 Shields Health Solutions

Shields Outcomes 2024 Report

This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
How Health System Specialty Pharmacy Can Support Pediatric Diabetes Patients 204 115 Shields Health Solutions

How Health System Specialty Pharmacy Can Support Pediatric Diabetes Patients

This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
How Spartanburg Regional Healthcare System Increased Patient Satisfaction by 24% with Specialty Pharmacy Services 204 115 Shields Health Solutions

How Spartanburg Regional Healthcare System Increased Patient Satisfaction by 24% with Specialty Pharmacy Services

This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Exploring AI’s Potential to Transform Specialty Pharmacy 204 115 Shields Health Solutions

Exploring AI’s Potential to Transform Specialty Pharmacy

This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.